Regina Castaneda, a research fellow in endocrinology at the Mayo Clinic in Jacksonville, Fla, said in a news release.Casteneda noted that previous studies of semaglutide (Ozempic/Wegovy) yielded similar findings.Achieving these outcomes with a second obesity medication may indicate a broader efficacy trend for pairing these two classes of medications, Castenada said.More women are using hormone therapy to manage menopause symptoms like hot flashes and night sweats, following research that found such therapy didnt increase risk of diseases like breast cancer and heart disease as dramatically as previously thought.Menopause-related hormone changes often result in increased belly fat and decreased muscle mass, as well as changes in metabolism that contribute to weight gain, researchers said in background notes.For the new study, researchers tracked the weight of 120 postmenopausal women prescribed Zepbound
In TRIUMPH-4, 18.2% of participants on retatrutide 12 mg discontinued due to adverse events, compared to 12.2% on the 9 mg dose and just 4.0% on placebo
Recognising the Signs of Low Vitamin B12 Levels B12 deficiency presents with neurological symptoms tingling, balance problems, cognitive changes and haematological symptoms such as fatigue and pallor
Obesity, insulin resistance, type 2 diabetes, and visceral adiposity are now recognized as independent risk factors for colorectal adenomas and cancer
As microdosing is an experimental practice, it is essential to consult a licensed healthcare provider for medical advice before using it for weight management or blood sugar control, to reduce the risk and ensure safety
See full terms at NovoCarePharmacyTerms.com and WegovyTerms.com
.jpg)
